Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29058094 | 1.00 | TSHR (0.53) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL15655397 | 1.00 | TSHR (0.53) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL1148089 | 1.00 | TSHR (0.53) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL30925357 | 1.00 | TSHR (0.53) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL15656588 | 1.00 | TSHR (0.53) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL15657098 | 1.00 | TSHR (0.53) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL15655834 | 1.00 | TSHR (0.53) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL15657093 | 1.00 | TSHR (0.53) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL15658064 | 1.00 | TSHR (0.53) | TSHRTHRBEPHX1CES2CES1 | |
| SCHEMBL15656743 | 1.00 | TSHR (0.53) | TSHRTHRBEPHX1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111411512-B | Preparation method of super-hydrophobic fabric and super-hydrophobic fabric | 海泰纺织（苏州）有限公司 | 2024-05-21 | — | — | CN | disclosed |
| US-7015168-B2 | Low dielectric constant fluorine and carbon-containing silicon oxide dielectric material characterized by improved resistance to oxidation | LSI LOGIC CORPORATION (US) | 2006-03-21 | — | — | US | disclosed |
| US-20050098856-A1 | Low dielectric constant fluorine and carbon-containing silicon oxide dielectric material characterized by improved resistance to oxidation | BELL SEMICONDUCTOR, LLC | 2005-05-12 | — | — | US | disclosed |
| US-6858195-B2 | Process for forming a low dielectric constant fluorine and carbon-containing silicon oxide dielectric material | LSI LOGIC CORPORATION (US) | 2005-02-22 | — | — | US | disclosed |
| US-6649219-B2 | Reacting one or more organofluorosilanes with an oxidizing agent | LSI LOGIC CORPORATION | 2003-11-18 | — | — | US | disclosed |
| US-20030207750-A1 | Low dielectric constant fluorine and carbon-containing silicon oxide dielectric material characterized by improved resistance to oxidation | BELL SEMICONDUCTOR, LLC | 2003-11-06 | — | — | US | disclosed |
| US-6572925-B2 | Doped silica | LSI LOGIC CORPORATION | 2003-06-03 | — | — | US | disclosed |
| US-20020119326-A1 | Process for forming a low dielectric constant fluorine and carbon-containing silicon oxide dielectric material characterized by improved resistance to oxidation | HILCO PATENT ACQUISITION 56, LLC | 2002-08-29 | — | — | US | disclosed |
| US-20020117082-A1 | Process for forming a low dielectric constant fluorine and carbon-containing silicon oxide dielectric material characterized by improved resistance to oxidation | BELL SEMICONDUCTOR, LLC | 2002-08-29 | — | — | US | disclosed |
| US-20020119315-A1 | Process for forming a low dielectric constant fluorine and carbon-containing silicon oxide dielectric material characterized by improved resistance to oxidation | HILCO PATENT ACQUISITION 56, LLC | 2002-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020117082-A1 | Process for forming a low dielectric constant fluorine and carbon-containing silicon oxide dielectric material characterized by improved resistance to oxidation | SCO2, CBR1, NOXO1 | TSHR 2791/4885THRB 4210/4885EPHX1 2989/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.